Skip to main content
ShockWave Medical, Inc. (SWAV)
NASDAQ: SWAV · IEX Real-Time Price · USD
330.00
+1.01 (0.31%)
At close: Apr 26, 2024, 4:00 PM
329.50
-0.50 (-0.15%)
After-hours: Apr 26, 2024, 7:20 PM EDT

ShockWave Medical Revenue

In the year 2023, ShockWave Medical had annual revenue of $730.23M with 49.11% growth. Revenue in the quarter ending December 31, 2023 was $202.98M with 40.93% year-over-year growth.

Revenue (ttm)
$730.23M
Revenue Growth
+49.11%
P/S Ratio
16.94
Revenue / Employee
$497,432
Employees
1,468
Market Cap
12.37B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023730.23M240.50M49.11%
Dec 31, 2022489.73M252.59M106.51%
Dec 31, 2021237.15M169.36M249.83%
Dec 31, 202067.79M24.86M57.92%
Dec 31, 201942.93M30.66M250.05%
Dec 31, 201812.26M10.54M613.38%
Dec 31, 20171.72M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fresenius Medical Care AG & Co. KGaA 21.62B
DaVita 12.14B
Charles River Laboratories International 4.13B
Dr. Reddy's Laboratories 2.99B
Revvity 2.75B
Royalty Pharma 2.35B
Medpace Holdings 1.96B
Neurocrine Biosciences 1.89B
Revenue Rankings

SWAV News

More News